Member access

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesHot NewsMost Read NewsRecomm.Business LeadersVideosCalendar 

Research and Markets: Global Next Generation Sequencing (NGS) Market to 2016

10/14/2013 | 01:53pm US/Eastern

Research and Markets (http://www.researchandmarkets.com/research/xb3r3d/global_next) has announced the addition of the "Global Next Generation Sequencing Market to 2016" report to their offering.

Global Next Generation Sequencing Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the EMEA and APAC regions; it also covers the Global Next Generation Sequencing market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Further, the report states that one of the key challenges in the market is the low adoption of genomic technology compared to other sequence analysis technologies, especially among large biotechnology companies. This is mainly because of logistical problems such as instrument complexity, problems in data storage, automation, and sample preparation.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Key questions answered in this report:

- What will the market size be in 2016 and what will the growth rate be?

- What are the key market trends?

- What is driving this market?

- What are the challenges to market growth?

- Who are the key vendors in this market space?

- What are the market opportunities and threats faced by the key vendors?

- What are the strengths and weaknesses of these key vendors?

Key Topics Covered:

01. Executive Summary

02. Scope of the Report

03. Market Research Methodology

04. List of Abbreviations

05. Introduction

06. Market Landscape

07. Market Segmentation by Application

08. Market Segmentation by Technology

09. Market Segmentation by Product

10. Market Segmentation by End-users

11. Geographical Segmentation

12. Key Leading Countries

13. Buying Criteria

14. Market Growth Drivers

15. Drivers and their Impact

16. Market Challenges

17. Impact of Drivers and Challenges

18. Market Trends

19. Trends and their Impact

20. Vendor Landscape

21. Key Vendor Analysis

For more information visit http://www.researchandmarkets.com/research/xb3r3d/global_next

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Bioinformatics


© Business Wire 2013
React to this article
Latest news
Date Title
<1m ago ROLLS ROYCE : *morgan stanley starts rolls-royce with 'overweight' - price target 1040 pence
<1m ago INFRASTRATA : Gets EU Grant Approval For Islandmagee Gas Storage Project
<1m ago RESEARCH AND MARKETS : Hand Wash Market in South Africa 2015-2019: Key Vendors are Farmasi, FMCG, Reckitt Benckiser and Statestrong
3m ago KEFI MINERALS : Raises GBP4.9 Million In Placing To Fund Tulu Kapi Short-Term (ALLISS)
3m ago CONNEMARA MINING : Says Oldcastle Drilling Finds No Mineralisation
3m ago BARCLAYS : *morgan stanley raises barclays price target to 270 (265) pence - 'equal-weight'
4m ago ELEKTROMOTIVE : Issue Of The Fourth Sub-Tranche Of Tranche 2 Notes
4m ago ELLEN : hires new CEO
4m ago AVI TECH ELECTRONICS : Disclosure Of Interest/ Changes In Interest Of Director/ Chief Executive Officer - Disclosure Of Interest/Changes In Interest Of Director
4m ago BANK INDONESIA : Broad Money Remained Its Upward Trend Growth
Latest news
Advertisement
Hot News 
FRENCH CONNECTION : Interim Management Statement 26th November 2014 (pdf)
FINDEL : Shares Fall As Pretax Loss Widens On Kleeneze Impairment
DAEJAN : Profit Jumps On Valuation Gains
ROMA : Bologna F.C. 1909 Taps New CEO
CARDIO3 BIO : 26/11/2014 - Cardio3 BioSciences announces the nomination of three Co-Principal Investigators for its CHART-2 phase III clinical trial of C-Cure® for the treatment of heart failure
Most Read News
1d agoDJCEOS' TEST : Contending With Activist Investors -2-
1d ago DP WORLD : Belgian operations disrupted
1d ago FLOWSERVE : McCANNA Introduces In-Line Maintainable Cryogenic Valve
1d agoDJCHINA LNG : Signed Preliminary Liquefied-Natural-Gas Agreement With Sinopec Unit
1d ago CUBIC : To Present At Credit Suisse Global Industrials Conference
Most recommended articles
4m agoDJUK Economy More Reliant on Consumer Spending
4m ago Bitcoin exchange Kraken to help in Mt. Gox bankruptcy
5m ago Thomas Cook hit by shock CEO departure, slowing growth
8m ago AVIVA : British insurer Aviva to shut $2 billion fund of hedge funds unit
13m agoDJECB May Buy Sovereign Bonds Early 2015
Dynamic quotes  
ON
| OFF